HepaRegeniX GmbH | WebDisclosure

BRIEF

published on 10/22/2024 at 10:35, 1 month 30 days ago

HepaRegeniX Appoints Dr. Martin Bonde as New Chair of the Board

HepaRegeniX HRX-215 Liver Regeneration Martin Bonde Biotech Leadership
BRIEF

published on 10/22/2024 at 10:35, 1 month 30 days ago

HepaRegeniX nomme le Dr Martin Bonde au poste de nouveau président du conseil d'administration

HepaRegeniX HRX-215 Régénération Du Foie Martin Bonde Leadership En Biotechnologie
PRESS RELEASE

published on 10/22/2024 at 10:30, 1 month 30 days ago

HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board
HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board, succeeding Elias Papatheodorou who becomes CEO. Preparation for clinical trials ongoing

Clinical Trials HepaRegeniX Liver Regeneration Chair Of The Board Dr. Martin Bonde
BRIEF

published on 07/10/2024 at 09:05, 5 months 11 days ago

HepaRegeniX Raises €15 Million to Advance Liver Regeneration Drug

Clinical Trials HepaRegeniX HRX-215 Liver Regeneration Series C Funding
BRIEF

published on 07/10/2024 at 09:05, 5 months 11 days ago

HepaRegeniX lève 15 millions d'euros pour faire progresser un médicament contre la régénération du foie

Essais Cliniques HepaRegeniX HRX-215 Régénération Du Foie Financement De Série C
PRESS RELEASE

published on 07/10/2024 at 09:00, 5 months 11 days ago

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
HepaRegeniX raises €15 million Series C round led by Vesalius Biocapital IV to advance clinical development of HRX-215 for liver regeneration, appoints Elias Papatheodorou as CEO and Dr. Linda Greenbaum as CMO

Clinical Development HepaRegeniX HRX-215 Liver Regeneration €15 Million Series C Round
BRIEF

published on 03/14/2024 at 16:20, 9 months 7 days ago

HepaRegeniX Announces Promising Data for Liver Disease Treatment with MKK4 Inhibitor HRX-215

Clinical Study HepaRegeniX HRX-215 Liver Regeneration MKK4 Inhibitor
BRIEF

published on 03/14/2024 at 16:20, 9 months 7 days ago

HepaRegeniX annonce des données prometteuses pour le traitement des maladies du foie avec l'inhibiteur MKK4 HRX-215

Étude Clinique HepaRegeniX HRX-215 Régénération Du Foie Inhibiteur MKK4
PRESS RELEASE

published on 03/14/2024 at 16:15, 9 months 7 days ago

HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
HepaRegeniX publishes data on MKK4 inhibitor HRX-215 for acute and chronic liver diseases in Cell journal, showing safety, liver regeneration, and potential in oncological liver surgery and transplantation

Régénération HepaRegeniX MKK4 Inhibitor Liver Diseases Oncological Surgery

Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 49 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 54 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 24 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 3 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 9 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 44 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 58 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 37 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 37 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News